Capital Group Global Equity Fund (LUX) ZdRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.5 | 15.5 | -5.3 | 11.2 | 8.1 | |
+/-Cat | 0.9 | -2.6 | 4.0 | -1.6 | -1.9 | |
+/-B’mrk | -0.7 | -4.2 | 2.4 | -4.1 | -4.4 | |
Category: Global Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar Global TME NR USD |
Key Stats | ||
NAV 27/09/2024 | USD 45.02 | |
Day Change | -0.34% | |
Morningstar Category™ | Global Large-Cap Blend Equity | |
ISIN | LU0817819070 | |
Fund Size (Mil) 27/09/2024 | USD 675.19 | |
Share Class Size (Mil) 27/09/2024 | EUR 3.40 | |
Max Initial Charge | 5.25% | |
Ongoing Charge 31/07/2024 | 0.90% |
Investment Objective: Capital Group Global Equity Fund (LUX) Zd |
Long-term capital growth through investment primarily in listed Equity, researched and selected on a world-wide basis. Unlisted securities may also be purchased, subject to the relevant provisions of the "General Investment Guidelines and Restrictions". |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Philip Winston 22/01/2020 | ||
William Robbins 22/01/2020 | ||
Click here to see others | ||
Inception Date 25/04/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Global TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Capital Group Global Equity Fund (LUX) Zd | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 2.98 |
Broadcom Inc | Technology | 2.81 |
Microsoft Corp | Technology | 2.29 |
AstraZeneca PLC | Healthcare | 2.16 |
Apple Inc | Technology | 2.14 |
Increase Decrease New since last portfolio | ||
Capital Group Global Equity Fund (LUX) Zd |